利用RNA-Seq鉴定儿童B-ALL的IGH疾病克隆用于MRD监测
研究采用RNA-Seq在258例儿童B细胞急性淋巴细胞白血病(B-ALL)样本中鉴定IGH疾病克隆序列用于MRD监测;90.3%患者可鉴定出IGH疾病克隆,且RNA-Seq较Sanger测序多发现43%的克隆;在缺乏敏感IGH靶点的患者中,靶向NGS IGH MRD与RQ-PCR MRD高度相关且复发预测更优。
要点
- RNA-Seq可在90.3%儿童B-ALL中鉴定IGH疾病克隆,中位2个/患者。
- RNA-Seq较Sanger测序多发现43%的IGH疾病克隆,覆盖90.8%的Sanger克隆。
- 靶向NGS IGH MRD与RQ-PCR MRD高度相关(R=0.93),复发预测更优。
核心结论
- RNA-Seq可鉴定患者特异性克隆性IGH连接序列用于MRD监测,拓展其在儿童B-ALL分子诊断中的用途。
研究设计与样本
- 研究纳入258例儿童B-ALL诊断样本,采用RNA-Seq鉴定IGH疾病克隆序列并与Sanger测序比较。
主要发现
- 高超二倍体患者IGH疾病克隆重数最多(中位3),DUX4亚型最少(中位1)。
- Sanger测序发现的IGH疾病克隆中90.8%也被RNA-Seq鉴定,RNA-Seq额外多发现43%的克隆。
- 69例缺乏敏感IGH靶点的患者中,靶向NGS IGH MRD与RQ-PCR MRD高度相关(R=0.93;P=1.3×10-14),且复发预测优于使用非IGH靶点的常规RQ-PCR MRD。
临床怎么用
- 对缺乏敏感IGH靶点的儿童B-ALL患者,可考虑用RNA-Seq鉴定IGH疾病克隆并采用靶向NGS进行MRD监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Identifying patient-specific clonal IGH/TCR junctional sequences is critical for minimal residual disease (MRD) monitoring. Conventionally these junctional sequences are identified using laborious Sanger sequencing of excised heteroduplex bands. We found that the IGH is highly expressed in our diagnostic B-cell acute lymphoblastic leukemia (B-ALL) samples using RNA-Seq. Therefore, we used RNA-Seq to identify IGH disease clone sequences in 258 childhood B-ALL samples for MRD monitoring. The amount of background IGH rearrangements uncovered by RNA-Seq followed the Zipf's law with IGH disease clones easily identified as outliers. Four hundred and ninety-seven IGH disease clones (median 2, range 0-7 clones/patient) are identified in 90.3% of patients. High hyperdiploid patients have the most IGH disease clones (median 3) while DUX4 subtype has the least (median 1) due to the rearrangements involving the IGH locus. In all, 90.8% of IGH disease clones found by Sanger sequencing are also identified by RNA-Seq. In addition, RNA-Seq identified 43% more IGH disease clones. In 69 patients lacking sensitive IGH targets, targeted NGS IGH MRD showed high correlation (R = 0.93; P = 1.3 × 10-14), better relapse prediction than conventional RQ-PCR MRD using non-IGH targets. In conclusion, RNA-Seq can identify patient-specific clonal IGH junctional sequences for MRD monitoring, adding to its usefulness for molecular diagnosis in childhood B-ALL.
引用
- Li Z, Jiang N, Lim EH, et al. Identifying IGH disease clones for MRD monitoring in childhood B-cell acute lymphoblastic leukemia using RNA-Seq. Leukemia. 2020. PMID: 32099036. doi:10.1038/s41375-020-0774-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。